Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine in STEMI Patients at 3 Years of Follow-up (CIRCUS II)
NCT02934217Phase 3Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Mar 2014
- Primary completion
- Jun 2017
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of cyclosporine in ST elevation myocardial infarction (STEMI) (2 arms), sponsored by Hospices Civils de Lyon. Primary endpoint: Combined incidence of total mortality, hospitalization for heart failure, and LV remodeling at 12 months. Started Mar 2014; status: completed.
02
Drugs
cyclosporine
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT02934217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02934217.